How much does clinical decision support software cost? Every published vendor price, and what a quote includes

The short answer: clinical decision support software is priced in five different ways, and the category has no single number because the products are not the same shape. Individual subscriptions that publish a price range from free to $179.99 a year for epocrates+ and $29.99 a month for UpToDate Lexidrug. Per-clinician tools like ours run $29 to $59 per clinician per month. Everything sold to institutions, which is most of the market by revenue, is quoted per organization and published nowhere. If you are budgeting, the useful question is not "what does clinical decision support software cost" but "which of the five pricing models am I buying under", because that decides whether you can look the price up at all.

This guide covers what each model actually means for your budget, what a solo prescriber, a small practice and a health system each end up paying, and the costs that sit outside the license line and surprise people at implementation.

How is clinical decision support software priced?

Five models cover essentially the whole category.

Free and ad-funded. Medscape is free with no in-app purchases at all, and OpenEvidence is free to NPI-verified US clinicians. Both are funded by advertising, largely pharmaceutical. This is a real option, not a trap, but it is worth knowing what is paying for it.

Freemium with a paid upgrade. Epocrates gives you drug monographs, an interaction checker and a pill identifier free after registration, and charges for the disease and infectious disease content on top. The free tier is genuinely useful and many clinicians never leave it.

Flat individual subscription. A published price, one seat, buy it today. UpToDate Lexidrug at $29.99 a month and epocrates+ at $179.99 a year are the two clean examples. This is the only part of the market where you can compare prices without talking to anyone.

Per-clinician, per-month SaaS. The standard software pattern: a published rate per seat, cheaper per head as you add seats, billed annually. This is how we price, and it is increasingly how newer clinical tools price, because buyers now expect to see the number before the call.

Quoted institutional contracts. Priced on user count, licensed beds, sites or FTEs, negotiated per organization, published nowhere. UpToDate, Micromedex and DynaMed all sit here for any serious deployment, and Lexidrug does too once you want the EHR integration.

What does clinical decision support software cost per user?

Here is the honest state of published pricing as of August 2026, re-verified at each vendor's own source rather than taken from software directories.

The pattern worth noticing is that price transparency tracks who the buyer is, not how good the product is. Everything aimed at a clinician with a credit card has a price on it. Everything aimed at a procurement department does not. UpToDate and Lexidrug make this unmistakable: same vendor, same company, and one publishes $29.99 a month while the other publishes nothing at all.

Why do some vendors not publish pricing at all?

Because a published number becomes a ceiling. Quote-only pricing lets a vendor charge a large academic medical center and a twelve-provider clinic very differently for identical content, and it keeps any figure from anchoring the next renewal. It is standard enterprise software practice and it is not unique to healthcare.

The practical consequence is that the work of producing a comparable number has been handed to you. Software directories fill the vacuum with confident figures no vendor ever published, and those figures contradict each other by hundreds of dollars for the same product, which is a good reason not to build a budget on them. If you are buying at organization scale, the institutional license cost guide walks through what actually drives a quote and the ten questions that get vendors to answer in comparable terms.

What should a solo clinician budget?

Less than most people assume, because the free tiers in this category are strong. A prescriber who mainly needs drug facts, an interaction check and a pill identifier can work from the free Epocrates tier and Medscape indefinitely, and OpenEvidence answers clinical questions with cited literature at no cost. Plenty of experienced clinicians run entirely on free tools.

You start paying when you need something specific. Long-form disease content to read means a reference subscription, and UpToDate will not quote you a figure until you tell it your country and your professional role. Deep drug monographs mean Lexidrug at $29.99 a month, which is about $360 a year. Disease content on top of a fast drug lookup means epocrates+ at $179.99 a year. Checks that run together at the moment you prescribe are a different job again, and that is a $39 per month tier for us.

The single best move before any of this is to find out what you already have. Hospital libraries, health systems and training programs frequently hold licenses that staff can use for free, and a lot of clinicians quietly pay out of pocket every year for access their employer already provides.

What should a small practice or clinic budget?

This group gets the worst deal in the category and rarely notices, because the default behavior is to renew individual subscriptions one clinician at a time. Ten prescribers each paying for epocrates+ is $1,799.90 a year with no volume discount, no shared configuration and no central billing.

Two things change that. First, ask about group rates even when they are not advertised: Epocrates prices group subscriptions in tiers by license count, and UpToDate handles small groups through its store with rates that vary by user count. Second, compare against tools that publish a multi-seat rate, because a published $29 per clinician per month is a number you can plan against without a sales cycle.

Whatever you land on, put the renewal dates somewhere you will see them coming. Clinical content contracts renew quietly and annually, and practices routinely discover a subscription nobody has opened in a year only when they finally get an alert on the recurring charges hitting the account. An unused seat costs exactly as much as a used one.

What does an institutional or enterprise license cost?

Quoted, always, and driven by a small set of variables. User count is the starting point, and how "user" gets defined (prescribers only, or every badge in the building) moves the total more than any discount you negotiate afterwards. Hospital deals often key off licensed beds instead. Multi-site groups get priced per location, so whether your fifteen urgent care clinics count as one organization or fifteen can dominate every other line in the quote.

UpToDate publishes the one threshold worth knowing: medical groups and organizations with 20 or more users are directed to enterprise solutions or to contact sales, while smaller groups buy through the store. Sitting just above that line is an awkward place, because you get quoted as an enterprise customer without any of the negotiating weight of a health system.

Beyond headcount, the levers are contract term, whether EHR integration is a line item, which content modules are bundled, and whether off-site and mobile access are included or sold on top. All of that is covered in detail, with the questions to put in an RFP, in the guide to institutional and group licensing.

What is not included in the license price?

Three costs sit outside the subscription line and are the usual source of budget surprises.

Integration and implementation. Launching a drug reference from inside Epic, MEDITECH or Cerner is typically priced separately from the content license, and it carries an implementation effort on your side as well as the vendor's fee. It is also the line most likely to come off the quote if you say you will start without it.

Authentication and access management. Single sign-on, off-site access and personal accounts for staff working from home are frequently extras. They are also the features clinicians notice immediately when they are missing.

The seats nobody uses. This is the largest hidden cost in the category and the easiest to fix. Institutional contracts are usually priced on how many people could log in rather than how many do. Ask for utilization reporting as a contract term, not a favor, and take the data into the renewal.

How do free tools fit into a real budget?

Seriously, and they should be in the plan rather than treated as a fallback. Medscape's free tier carries a large drug database, a multi-drug interaction checker, a pill identifier, several hundred calculators and free CME. OpenEvidence answers clinical questions with citations and is free to verified US clinicians.

The caveat is governance rather than quality. Vendor-level HIPAA capability is not the same as your employer permitting a tool, and several health systems instruct staff in writing not to enter patient information into consumer-facing AI clinical tools because the organization has not signed acceptable terms of its own. If you are choosing for an organization rather than yourself, that question belongs early in the evaluation, not after rollout. We worked through the specifics of that distinction in OpenEvidence vs ChatGPT.

How to build the budget

Start with the job, not the vendor. Reading up on a condition, looking up a drug fact, and running checks before you sign are three different jobs, and the products that do them well are priced very differently. Organizations that skip this step end up paying enterprise prices for two tools that overlap on the same job while the third gap stays open.

Then audit what you already license, count who will genuinely use the thing, and get parallel quotes with a per-user figure at your exact headcount. Ask for a scoped pilot with usage reporting before committing the whole organization. Every one of those steps costs nothing and each one has a decent chance of removing the purchase entirely.

Where to go next

For the numbers on a specific vendor, we keep individual breakdowns of what a Lexicomp subscription costs, what UpToDate costs, what Epocrates costs and why Micromedex has no list price. To see the products side by side on cost and capability, start with the guide to the best clinical decision support software. If what you actually need is the check itself rather than a reference to read, the drug interaction checker shows what one card looks like, and our pricing is published in full, per clinician, including team seats.